Immune hyporesponsiveness to amyloid β-peptide in amyloid precursor protein transgenic mice: Implications for the pathogenesis and treatment of Alzheimer's disease

Keyphrases

• Alzheimer's Disease 100%
• Transgenic Mice 100%
• Amyloid-β Peptide 100%
• Amyloid Precursor Protein 100%
• Immune Hyporesponsiveness 100%
• Neuropathology 66%
• Vaccination 33%
• Antibody Response 33%
• Immunization 33%
• Immune Response 33%
• Antibody Production 33%
• Brain Regions 33%
• Dementia 33%
• Pathological Changes 33%
• Mice Transgenic 33%
• Adaptive Immune Response 33%
• Amyloid Protein 33%
• Down Syndrome 33%
• Cellular Immune Response 33%
• Secondary Inflammation 33%
• Prion 33%
• Specific T Cells 33%
• Transgenic Expression 33%
• Human Amyloid Precursor Protein 33%
• B-cell Epitope 33%
• T Cell Help 33%
• Antibody Immune Response 33%
• Presenilin 1 mutation 33%
• B Cell Tolerance 33%

Neuroscience

• Amyloid 100%
• Treatment of Alzheimer's Disease 100%
• Amyloid Precursor Protein 100%
• B Cell 50%
• T Cell 50%
• Alzheimer's Disease 25%
• Promoter Region 25%
• Bovine Serum Albumin 25%
• Epitope 25%
• Down Syndrome 25%
• Prion 25%
• Amyloid A Protein 25%
• Presenilin 25%
• Antibody Production 25%

Immunology and Microbiology

• Precursor 100%
• Transgenic Mouse 100%
• T Cell 50%
• Mouse 25%
• B Cell 25%
• Antibody Response 25%
• Adaptive Immune System 25%
• Vaccination Policy 25%
• Immune Response 25%
• Promoter Region 25%
• Antibody Production 25%
• Epitope 25%
• Transgenics 25%
• Adoptive Immunity 25%
• Brain Region 25%
• Prion 25%
• B-Cell Tolerance 25%